Premier American closes $15M bought deal offering

Executive Summary

• Premier American Uranium Inc. has closed its previously announced bought deal private placement, raising gross proceeds of approximately C$15 million, inclusive of the full exercise of the underwriter's over-allotment option.
• The company sold 16,666,666 units at a price of C$0.90 per unit, with net proceeds designated for the exploration and advancement of uranium projects in New Mexico and Wyoming, as well as for working capital and general corporate purposes.
• The transaction includes significant insider participation from IsoEnergy Ltd. and Sachem Cove Special Opportunities Fund LP, who are purchasing an aggregate of 2,556,500 units, and the issuance of incentive stock options to directors, officers, and advisers.

Key Details

• Gross Proceeds: Approximately C$15 million (includes full exercise of underwriter's option).
• Units Sold: 16,666,666 units.
• Price Per Unit: C$0.90.
• Warrant Terms (Investor): Each unit includes one-half of one common share purchase warrant. Each whole warrant entitles the holder to purchase one common share at an exercise price of $1.26. Warrants expire on February 3, 2029.
• Underwriter Compensation: Aggregate cash fees of $823,468.46 and 914,964 non-transferable common share purchase warrants. Broker warrants are exercisable at the offering price (C$0.90) until February 3, 2029.
• Underwriters: Red Cloud Securities Inc. (lead underwriter and sole bookrunner), Haywood Securities Inc., and Beacon Securities Ltd.
• Use of Proceeds: Exploration and advancement of uranium projects in New Mexico and Wyoming; working capital; general corporate purposes.
• Insider Participation: IsoEnergy Ltd. and Sachem Cove Special Opportunities Fund LP are participating directly or through affiliates, purchasing an aggregate of 2,556,500 units for $2,300,850. This constitutes a related-party transaction exempt from formal valuation and minority shareholder approval requirements under MI 61-101.
• Regulatory Status: Closing is subject to final approval of the TSX Venture Exchange. Securities sold to Canadian purchasers under the listed issuer financing exemption are immediately freely tradable. Securities sold outside Canada are not subject to a four-month hold period.
• Option Grants: The company granted 2,115,000 incentive stock options to certain directors, officers, consultants, and advisers.
  • Exercise Price: C$0.90 per common share.
  • Term: Five years.
  • Vesting: In tranches over a period of three years.
  • Status: Subject to TSX Venture Exchange approval.
• Offering Document: Amended and restated offering document dated January 22, 2026, available on SEDAR+ and the company website.

Notable Quotes

• No direct quotes from the CEO/President were included in the provided text.